Cargando…
IL-22 production of effector CD4(+) T-cells is altered in SLE patients
BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by T-cell-dependent B-cell activation and altered T-cell response. Co-stimulatory and co-inhibitory molecules regulate and exert T-cell differentiation, survival and cytokine production. CD134(+) and PD-1(+) T-cell...
Autores principales: | Dolff, Sebastian, Scharpenberg, Claudia, Specker, Christof, Kribben, Andreas, Witzke, Oliver, Wilde, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643306/ https://www.ncbi.nlm.nih.gov/pubmed/31331400 http://dx.doi.org/10.1186/s40001-019-0385-6 |
Ejemplares similares
-
BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease
por: Oster, Christoph, et al.
Publicado: (2019) -
Abnormal Expression Pattern of the IL-2 Receptor β-Chain on CD4(+) T Cells in ANCA-Associated Vasculitis
por: Wilde, Benjamin, et al.
Publicado: (2014) -
Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus
por: Dolff, Sebastian, et al.
Publicado: (2010) -
Chloroquine Suppresses Effector B-Cell Functions and Has Differential Impact on Regulatory B-Cell Subsets
por: Ma, Xin, et al.
Publicado: (2022) -
Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis
por: Friebus-Kardash, Justa, et al.
Publicado: (2019)